Effect of homocysteine-lowering treatment with folic acid plus pyridoxine on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

E.G.J. Vermeulen; C.D.A. Stehouwer; J.W.R. Twisk; M. van den Berg; S.C. de Jong; A.J.C. Mackaay; C.M.C. van Campen; F.C. Visser; C.A.J.M. Jakobs; E.J. Bulterijs; J.A. Rauwerda

doi:https://doi.org/10.1016/S0140-6736(99)07391-2

Effect of homocysteine-lowering treatment with folic acid plus pyridoxine on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

E.G.J. Vermeulen, C.D.A. Stehouwer, J.W.R. Twisk, M. van den Berg, S.C. de Jong, A.J.C. Mackaay, C.M.C. van Campen, F.C. Visser, C.A.J.M. Jakobs, E.J. Bulterijs, J.A. Rauwerda

Research output: Contribution to journal › Article › Academic › peer-review

323 Citations (Scopus)

Original language	English
Pages (from-to)	517-22
Journal	Lancet
Volume	355
DOIs	https://doi.org/10.1016/S0140-6736(99)07391-2
Publication status	Published - 2000

Access to Document

https://doi.org/10.1016/S0140-6736(99)07391-2

Cite this

Vermeulen, E. G. J., Stehouwer, C. D. A., Twisk, J. W. R., van den Berg, M., de Jong, S. C., Mackaay, A. J. C., van Campen, C. M. C., Visser, F. C., Jakobs, C. A. J. M., Bulterijs, E. J., & Rauwerda, J. A. (2000). Effect of homocysteine-lowering treatment with folic acid plus pyridoxine on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet, 355, 517-22. https://doi.org/10.1016/S0140-6736(99)07391-2

@article{08b73b93a36a414f9dd4c1f49e757864,

title = "Effect of homocysteine-lowering treatment with folic acid plus pyridoxine on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.",

author = "E.G.J. Vermeulen and C.D.A. Stehouwer and J.W.R. Twisk and {van den Berg}, M. and {de Jong}, S.C. and A.J.C. Mackaay and {van Campen}, C.M.C. and F.C. Visser and C.A.J.M. Jakobs and E.J. Bulterijs and J.A. Rauwerda",

year = "2000",

doi = "https://doi.org/10.1016/S0140-6736(99)07391-2",

language = "English",

volume = "355",

pages = "517--22",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

}

Vermeulen, EGJ, Stehouwer, CDA, Twisk, JWR, van den Berg, M, de Jong, SC, Mackaay, AJC, van Campen, CMC, Visser, FC, Jakobs, CAJM, Bulterijs, EJ & Rauwerda, JA 2000, 'Effect of homocysteine-lowering treatment with folic acid plus pyridoxine on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.', Lancet, vol. 355, pp. 517-22. https://doi.org/10.1016/S0140-6736(99)07391-2

TY - JOUR

T1 - Effect of homocysteine-lowering treatment with folic acid plus pyridoxine on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

AU - Vermeulen, E.G.J.

AU - Stehouwer, C.D.A.

AU - Twisk, J.W.R.

AU - van den Berg, M.

AU - de Jong, S.C.

AU - Mackaay, A.J.C.

AU - van Campen, C.M.C.

AU - Visser, F.C.

AU - Jakobs, C.A.J.M.

AU - Bulterijs, E.J.

AU - Rauwerda, J.A.

PY - 2000

Y1 - 2000

U2 - https://doi.org/10.1016/S0140-6736(99)07391-2

DO - https://doi.org/10.1016/S0140-6736(99)07391-2

M3 - Article

SN - 0140-6736

VL - 355

SP - 517

EP - 522

JO - Lancet

JF - Lancet

ER -